---
title: "Sakar Healthcare Ltd (SAKAR) — Share Price, Financials & Analysis"
symbol: "SAKAR"
company: "Sakar Healthcare Ltd"
canonical: "https://tapetide.com/stocks/SAKAR"
isin: "INE732S01012"
nse_symbol: "SAKAR"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 2477.97
generated_at: "2026-09-13T18:25:45.491Z"
---

# Sakar Healthcare Ltd (SAKAR)

Canonical page: https://tapetide.com/stocks/SAKAR

## Company

- **NSE Symbol:** SAKAR
- **ISIN:** INE732S01012
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2019-04-11
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** sakarhealthcare.com

## About

Incorporated in 2004, Sakar Healthcare Ltd is in the business of manufacturing Research & Development of Pharmaceutical products[1]

## Latest Price

- **Price:** ₹1158.55
- **Change:** +41.25 (+3.69%)
- **Open:** ₹1118
- **Day High:** ₹1195
- **Day Low:** ₹1096.05
- **Previous Close:** ₹1117.3
- **Volume:** 181225
- **As Of:** 2026-09-11T10:29:54+00:00

## Key Fundamentals

Observed at 2026-09-11T04:45:18.762691Z.

- **Market Cap:** ₹2477.97 Cr
- **Classification:** Microcap
- **P/E (reported):** 68.9
- **P/E (TTM):** 71.43
- **EPS (TTM):** ₹16.22
- **Book Value:** ₹145.82
- **Price to Book:** 7.66
- **Dividend Yield:** 0%
- **ROE:** 9.4%
- **ROCE:** 12.82%
- **Debt to Equity:** 0.22
- **Revenue (yearly):** ₹254 Cr
- **Net Income:** ₹30.5 Cr
- **EBITDA:** ₹71.2 Cr
- **52-Week High:** ₹1211
- **52-Week Low:** ₹328
- **RSI (14):** 69.79

## Tapetide Score

- **Score:** 44 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 25 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 63.03 | 9% |
| growth | 98.71 | 9% |
| momentum | 95.22 | 12% |
| ownership | 27.06 | 24% |
| quality | 59.77 | 22% |
| valuation | 25.67 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter
- Company has delivered good profit growth of 23.1% CAGR over last 5 years
- Company's median sales growth is 18.0% of last 10 years

### Weaknesses

- Stock is trading at 7.94 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 7.49% over last 3 years.
- Promoter holding has decreased over last 3 years: -8.20%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 44.75% | 101.31% | 37.98% |
| ebitda margin growth | -13.64% | -1.72% | 5.58% | 15.74% |
| net income growth | -6.36% | 74.29% | 34% | 23% |
| revenue growth | 4.49% | 41.98% | 24% | 22% |
| roce | -20.62% | 50.12% | 79.8% | 9.3% |
| roe | -6.72% | 53.34% | 6.66% | -21.4% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 34 | 37 | 43 | 41 | 43 | 43 | 50 | 53 | 58 | 70 | 71 | 73 |
| Expenses | 25 | 28 | 32 | 30 | 31 | 32 | 35 | 40 | 46 | 52 | 45 | 52 |
| Operating Profit | 9 | 9 | 11 | 11 | 12 | 12 | 16 | 13 | 11 | 19 | 26 | 21 |
| OPM % | 27 | 24 | 25 | 26 | 27 | 27 | 31 | 24 | 20 | 26 | 37 | 29 |
| Other Income | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 2 |
| Interest | 2 | 2 | 2 | 1 | 2 | 1 | 4 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 |
| Profit before tax | 4 | 3 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 11 | 18 | 15 |
| Tax % | 13 | 31 | 35 | 49 | 6 | 17 | 8 | 13 | 15 | 6 | 39 | 29 |
| Net Profit | 4 | 2 | 3 | 2 | 5 | 5 | 6 | 5 | 5 | 10 | 11 | 10 |
| EPS in Rs | 1.7 | 0.95 | 1.43 | 1.11 | 2.21 | 2.06 | 2.62 | 2.1 | 2.04 | 4.61 | 4.95 | 4.62 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 53 | 68 | 83 | 95 | 128 | 133 | 153 | 178 | 251 | 272 |
| Expenses | 40 | 51 | 63 | 72 | 99 | 100 | 115 | 128 | 182 | 195 |
| Operating Profit | 13 | 17 | 20 | 23 | 29 | 33 | 38 | 50 | 69 | 77 |
| OPM % | 24 | 25 | 24 | 24 | 23 | 25 | 25 | 28 | 27 | 28 |
| Other Income | 0 | 1 | 2 | 1 | 2 | 5 | 3 | 1 | 2 | 3 |
| Interest | 3 | 2 | 2 | 2 | 3 | 6 | 8 | 9 | 8 | 7 |
| Depreciation | 4 | 6 | 7 | 8 | 10 | 15 | 18 | 21 | 24 | 25 |
| Profit before tax | 6 | 9 | 12 | 13 | 19 | 17 | 16 | 22 | 40 | 49 |
| Tax % | 38 | 28 | 21 | 19 | 20 | 24 | 27 | 19 | 23 | — |
| Net Profit | 4 | 7 | 10 | 11 | 15 | 13 | 12 | 18 | 30 | 36 |
| EPS in Rs | 3.12 | 4.47 | 6.43 | 6.84 | 8.9 | 6.7 | 5.37 | 7.97 | 13.7 | 16.22 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 11 | 12 | 15 | 15 | 16 | 17 | 19 | 22 | 22 | 22 |
| Reserves | 25 | 39 | 57 | 66 | 83 | 110 | 154 | 241 | 264 | 302 |
| Borrowings | 24 | 11 | 11 | 17 | 43 | 93 | 119 | 79 | 86 | 71 |
| Other Liabilities | 11 | 18 | 15 | 17 | 37 | 47 | 44 | 47 | 43 | 86 |
| Total Liabilities | 71 | 81 | 97 | 115 | 178 | 268 | 336 | 389 | 415 | 481 |
| Fixed Assets | 49 | 53 | 64 | 66 | 69 | 205 | 267 | 314 | 309 | 326 |
| CWIP | 0 | 0 | 9 | 13 | 49 | 1 | 6 | 0 | 17 | 4 |
| Investments | 0 | 0 | 0 | 0 | 0 | 7 | 3 | 0 | 0 | 0 |
| Other Assets | 22 | 28 | 25 | 36 | 60 | 55 | 60 | 74 | 90 | 151 |
| Total Assets | 71 | 81 | 97 | 115 | 178 | 268 | 336 | 389 | 415 | 481 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2 | 5 | 16 | 19 | 15 | 36 | 33 | 24 | 34 | 49 |
| Cash from Investing Activity | -14 | -8 | -25 | -22 | -47 | -90 | -74 | -52 | -31 | -28 |
| Cash from Financing Activity | 13 | -13 | 9 | 3 | 32 | 55 | 41 | 27 | -3 | -21 |
| Net Cash Flow | 0 | -16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -13 | -4 | -9 | -4 | -32 | -62 | -49 | -35 | 2 | 21 |
| CFO/OP | 30 | 51 | 104 | 110 | 67 | 121 | 113 | 72 | 73 | 77 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 44 | 74 | 51 | 36 | 48 | 40 | 60 | 50 | 63 | 73 |
| Inventory Days | 114 | 51 | 70 | 92 | 112 | 69 | 76 | 121 | 193 | 207 |
| Days Payable | 51 | 57 | 41 | 46 | 141 | 149 | 129 | 120 | 93 | 153 |
| Cash Conversion Cycle | 107 | 68 | 80 | 83 | 19 | -39 | 7 | 51 | 163 | 127 |
| Working Capital Days | 67 | 98 | 31 | 31 | 2 | -11 | -6 | 29 | 52 | 45 |
| ROCE % | 15 | 14 | 16 | 16 | 13 | 12 | 9 | 7 | 9 | 12 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 54.15% | 53.15% | 53.15% | 53.15% | 53.15% | 53.58% | 53.58% | 52.86% | 52.86% | 52.86% | 52.86% | 52.52% |
| FIIs | 14.03% | 13.76% | 13.52% | 13.52% | 13.42% | 13.58% | 13.61% | 13.41% | 13.31% | 13.05% | 12.94% | 12.14% |
| DIIs | 0% | 10.62% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 11.36% | 11.32% | 11.37% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 16.37% | 16.61% | 16.78% | 16.8% | 16.88% | 15.75% | 15.93% | 15.86% | 16.01% | 16.59% | 18.11% | 19.96% |
| Others | 15.45% | 5.86% | 16.55% | 16.53% | 16.55% | 17.09% | 16.87% | 17.87% | 17.82% | 6.15% | 4.76% | 4.02% |
| No. of Shareholders | 6057 | 7001 | 7386 | 7313 | 7867 | 8598 | 8608 | 8115 | 7565 | 7069 | 9580 | 14734 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1053.1 | Buy |
| EMA (10) | 1070.33 | Buy |
| SMA (20) | 972.62 | Buy |
| EMA (20) | 1008.9 | Buy |
| SMA (50) | 913.17 | Buy |
| EMA (50) | 925.94 | Buy |
| SMA (100) | 827.46 | Buy |
| EMA (100) | 831.87 | Buy |
| SMA (200) | 643.15 | Buy |
| EMA (200) | 696.8 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 72.8 | Sell |
| MACD (12,26,9) | 67.93 | Buy |
| Stochastic (14,3,3) | 80.75 | Sell |
| ADX (14) | 28.57 | Buy |
| Williams %R (14) | -14.79 | Sell |
| ATR (14) | 61.99 | High Volatility |
| ROC (12) | 28.53 | Buy |
| Stoch RSI (14) | 85.06 | Sell |
| UO (7,14,28) | 61.2 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 1 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 1 analyst ratings, observed at 2026-09-11T04:45:18.739649+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-01 | [General Updates](https://nsearchives.nseindia.com/corporate/SAKAR_01092026120323_Announcement.pdf) |
| 2026-08-29 | [Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/SAKAR_29082026133425_Announcement.pdf) |
| 2026-08-27 | [Shareholders meeting](https://nsearchives.nseindia.com/corporate/SAKAR_27082026132350_Annual_Report_Submission.pdf) |
| 2026-08-01 | [Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/SAKAR_01082026161243_Announcement.pdf) |
| 2026-07-24 | [Press Release](https://nsearchives.nseindia.com/corporate/SAKAR_24072026201244_Announcement_-_Media_Release.pdf) |
| 2026-07-24 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_24072026201654_Intimation.pdf) |
| 2026-07-20 | [General Updates](https://nsearchives.nseindia.com/corporate/SAKAR_20072026163109_Intimation_JUNE_2026.pdf) |
| 2026-07-09 | [Disclosure under SEBI Takeover Regulations](https://nsearchives.nseindia.com/corporate/team_bbodade_15062026181446_SAKAR1.pdf) |
| 2026-07-08 | [General Updates](https://nsearchives.nseindia.com/corporate/SAKAR_08072026111701_74__2_.pdf) |
| 2026-06-26 | [Trading Window](https://nsearchives.nseindia.com/corporate/SAKAR_26062026155551_Trading_Window.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-03 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_03082026151351_Announcement_-_Transcript.pdf) |
| 2026-05-22 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_22052026162504_Announcement_-_Transcript.pdf) |
| 2026-02-17 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_17022026154339_Announcement_-_Transcript.pdf) |
| 2025-11-17 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_17112025185901_Announcement_-_Transcript_S.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-29 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_29072026170933_Announcement_-_Audio_Recording.pdf) |
| 2026-05-16 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_16052026145506_Announcement_-_Audio_Recording.pdf) |
| 2026-02-11 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_11022026161650_Announcement_-_Audio_Recording.pdf) |
| 2025-11-11 | [Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SAKAR_11112025184435_Announcement_-_Audio_Recording.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-28 | [Investor Presentation](https://nsearchives.nseindia.com/corporate/SAKAR_28072026140050_Announcement_-_Investor_Presentation.pdf) |
| 2026-05-13 | [Investor Presentation](https://nsearchives.nseindia.com/corporate/SAKAR_13052026211423_Announcement_-_Investor_Presentation.pdf) |
| 2026-02-10 | [Investor Presentation](https://nsearchives.nseindia.com/corporate/SAKAR_10022026123511_Announcement_-_Investor_Presentation1.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-24 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SAKAR_24072026121533_Outcome.pdf) |
| 2026-05-12 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SAKAR_12052026133518_Intimation.pdf) |
| 2026-05-12 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SAKAR_12052026120239_Outcome_12052026.pdf) |
| 2026-02-05 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SAKAR_05022026104240_Outcome.pdf) |
| 2026-02-05 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SAKAR_05022026104107_Outcome.pdf) |
| 2025-11-07 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SAKAR_07112025124158_Outcome_Signed.pdf) |
| 2025-11-07 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SAKAR_07112025123614_Outcome_Signed.pdf) |
| 2025-09-27 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SAKAR_27092025164057_Outcome.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 22 May 2026 - Exchange has sought clarification from Sakar Healthcare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (LODR) Regulations, 2015. On … | [Clarification - Financial Results 22 May 2026 - Exchange has sought clarification from Sakar Healthcare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (LODR) Regulations, 2015. On …](https://www.nseindia.com/get-quotes/equity?symbol=SAKAR) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/AR_30702_SAKAR_2025_2026_A_18392815_27082026132704.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/AR_27786_SAKAR_2024_2025_A_4597943_28082025130003.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/AR_25032_SAKAR_2023_2024_21082024123219.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/AR_22912_SAKAR_2022_2023_24082023153217_08242023160005.zip) |
| from nse | [Annual Report 2022 from nse](https://archives.nseindia.com/annual_reports/AR_20727_SAKAR_2021_2022_17082022161240_08172022170003.zip) |
| from nse | [Annual Report 2021 from nse](https://archives.nseindia.com/annual_reports/AR_18711_SAKAR_2020_2021_12082021190147_12082021200002.zip) |
| from nse | [Annual Report 2020 from nse](https://archives.nseindia.com/annual_reports/AR_16754_SAKAR_2019_2020_17082020165306_17082020170002.zip) |
| from nse | [Annual Report 2019 from nse](https://archives.nseindia.com/annual_reports/AR_15230_SAKAR_2018_2019_16082019164145_16082019170003.zip) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2022 | [Concall - Oct 2022](https://archives.nseindia.com/corporate/SAKAR_08102022110621_Sakar_Investor_Presentation.pdf) |
| Dec 2018 | [Concall - Dec 2018](https://archives.nseindia.com/corporate/SAKAR_12122018144641_SakarHealthcareInvestorPresentation_077.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:25:45.491Z.